A preoperative workup prior to minor surgery revealed hyperglycemia (serum glucose = 402 mg/dl; fasting glucose = 271 mg/dl) and marked glucosuria in an 8-year-old spayed female Siamese cat. No clinical signs characteristic of diabetes mellitus (polyuria, polydipsia, polyphagia, weight loss) had been noted. Severe hypoglycemia resulted after a 10fold overdose of NPH insulin (10 units rather than 1) was inadvertently administered to the cat by the owner. Despite medical management, neurologic signs including aggression, seizures, circling, and lack of menace response developed, and the cat died approximately 60 hours after the initial hypoglycemic episode.
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At necropsy, significant gross lesions were limited to an enlarged fatty liver. Significant histologic lesions involved liver (severe diffuse lipidosis), brain, and pancreas. In the brain, there was central chromatolysis of some hippocampal neurons, a degenerative change for which a specific cause was not definitively determined. In all examined areas of pancreas, most islets (85%; n = 191 islets) were composed partially or entirely of cells with abundant, pale, vacuolated cytoplasm ( Fig. 1 ). Deposition of islet amyloid was not observed, and a Congo red stain for amyloid was negative. Many islets (46%) containing vacuolated cells were mildly to densely infiltrated by small lymphocytes (Fig. 2 ). Small numbers of lymphocytes were occasionally noted around pancreatic ducts and around some vessels within the interstitium.
Pancreatic islet inflammation is unusual in domestic animals, so the lesions were characterized more completely. Deparaffinized 5-µm-thick sections of pancreas were processed for immunohistochemical evaluation. Similar sections of pancreas and lymph node from another adult cat were used as controls. All tissues were fixed by approximately 30 hours of immersion in 10% neutral buffered formalin and then processed routinely for paraffin embedment and sectioning. Polyclonal antibodies a used to investigate changes in islet cell populations were against synthetic human glucagon, synthetic human somatostatin, and synthetic human pancreatic polypeptide. A monoclonal anti-human insulin (clone AE9D6) a was used to immunolabel pancreatic islet ß cells. Polyclonal b,l and monoclonalc, 7 anti-human CD3 antibodies and a monoclonal anti-human CD5 c,7 were used as T-lymphocyte markers. Monoclonal antibodies to BLA.36 (clone A27-42), b,3 B-29, c,7 and MB-1 c,7 were used as B-lymphocyte markers. Biotin-streptavidin alkaline phosphatase a was used for detection of tissue-bound primary antibody.
In the control pancreas, the pattern of islet cell immunostaining for the different hormones was similar to that de- Received for publication January 11, 1996. scribed previously in cats. 12 The majority of cells in most islets were immunoreactive for insulin or glucagon. Compared with the control, the affected cat (judged subjectively) had similar to slightly decreased numbers of islet cells that stained positively for glucagon, somatostatin, and pancreatic polypeptide. Decrease in numbers of insulin-positive islet cells was marked ( Fig. 3 ). Vacuolated islet cells were not clearly immunoreactive for any of the hormones, so it was not possible to determine whether this change involved one or all islet cell subtypes. Because essentially all cells in affected islets were vacuolated, the change was probably not restricted to a specific islet cell subtype. Appropriate regions in the control lymph node were immunoreactive for T lymphocyte (paracortex) or B-lymphocyte (perifollicular mantle) markers, demonstrating that the antibodies could accurately label the lymphocyte subtypes in formalin-fixed tissues. In the affected cat, most islet-infiltrating lymphocytes reacted positively with T cell markers ( Fig. 4) and a few reacted with B cell markers. We were unable to further subclassify the infiltrating cells into CDS-positive/ CD4-negative (i.e., cytotoxic T cells) or CD4-positive/CD8negative (i.e., helper) T lymphocytes because those antibodies to which we had access (which are useful for flow cytometry or immunostaining of frozen tissues) did not label lymphocytes in the formalin-fixed control lymph node. In summary, pancreatic islet lesions were characterized by diffuse islet cell vacuolation, preferential loss of insulin-reactive islet cells, and islet infiltrates primarily of T lymphocytes.
Fasting hyperglycemia, presence of islet lesions, and the relative paucity of insulin-positive ß cells indicate that this cat was indeed diabetic. Absence of typical clinical signs suggests that the disease and the islet lesions were in a relatively early stage of development. Assays to determine whether serum insulin concentrations were deficient in this cat were not performed. Although the duration of action of therapeutic doses of NPH insulin is usually so short as to be considered ineffective in cats (< 12 hours), 11 the magnitude of the overdose in this particular individual was sufficient to cause profound hypoglycemia and complications leading to death.
Lymphocytic islet infiltrates were present in this pancreas with preferential if not specific loss of insulin-positive cells. These features suggest that immune-mediated islet cell destruction could have contributed to P-cell depletion in this cat, similar to events involved in development of human type I diabetes. Unlike insulin-dependent diabetes in humans, however, inflammatory destruction of insulin-producing cells has not been proven to be involved in development of diabetes in cats or most other domestic species. There is 1 previous report of lymphocytic islet adenitis (insulitis) in cats, 10 and the lesion has also been reported in young diabetic cattle 14, 15 and occasionally in diabetic dogs. 8 In most feline diabetics, the disease pathogenesis and histologic islet lesions have features more characteristic of human non-insulin-dependent (type II) diabetes. 6, 8 Rather than having an immune-mediated cause, insulin-dependent diabetes in most feline patients may represent an advanced stage of an initially non-insulin-dependent disease where significant ß-cell loss and dysfunction evolved secondary to sustained hypoglycemia and increasingly severe islet amyloid deposition. 6, 9, 11 Three different islet populations usually coexist in humans with recent-onset type I diabetes, representing various stages in the process of ß-cell destruction: 5,13 1) normal islets, 2) islets undergoing immune-mediated (lymphocytic) ß-cell destruction (insulitis), and 3) islets populated only by non-ß cells after all insulin-producing cells have been destroyed and the inflammation has subsided. Islets morphologically consistent with each of these populations were present in this cat. Cytotoxic T-lymphocyte-mediated lysis is an important mechanism of ß-cell killing, and during the inflammatory phase the islet infiltrates consist primarily of CD8positive/ CD4-negative cells and fewer CD4-positive/CD8-negative T lymphocytes. 2, 13 In this cat, immunostaining demonstrated that most of the infiltrating cells were T lymphocytes (i.e., CD3 and CD5 positive). More specific identification of the infiltrates as CD8-positive/CD4-negative cytotoxic T cells, which may have been specific effecters against insulin-producing ß cells, was not possible with the antibodies and the formalin-fixed tissue available to us.
The lesions in this cat suggest that islet infiltrates and immune-mediated destruction of islet cells may occur in and could contribute to development of diabetes mellitus in some cats. Viral infections may contribute in a complex way to development of autoimmune ß-cell destruction in humans 2, 5 and some nondomestic animals. 11, 15 This cat tested negative for feline leukemia virus but was not evaluated for feline infectious peritonitis virus or feline immunodeficiency virus infection.
